Posts tagged Model Portfolio
Review Of 5 Top Specialty Ingredients Stocks By Nirmal Bang | |
Company: | Model Portfolio, specialty ingredients |
Brokerage: | Nirmal Bang |
Date of report: | September 24, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 25% |
Summary: | Challenging environment could be an opportunity for select companies to gain market share |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Nirmal Bang, specialty ingredients |
Top 6 Festival Unlock Stocks By Axis Securities | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | September 25, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 19% |
Summary: | Festival Unlock Picks September 2021 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities |
Revised Nifty target is at 17,930 (22x P/E on FY23E EPS of Rs 815). Sensex target level is 59,800: ICICI Direct | |
Company: | Model Portfolio |
Brokerage: | ICICI-Direct |
Date of report: | September 9, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Positivity remains, stock specific action to prevail… |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | ICICI-Direct, NIFTY |
NIFTY target raised to 17400 + Top 16 Small Cap, Mid Cap and Large Cap Stocks To Buy | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | July 1, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 33% |
Summary: | Raise December NIFTY target to 17400 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities, NIFTY, Top Picks |
Latest List Of High Dividend Yield Stocks (6th May 2021) By HDFC Sec | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | March 16, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 14.6% |
Summary: | table of companies (CNX 500 stocks) that offer dividend yield of 3.00% and above |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | HDFC Sec |
21 Stocks for Medium/Long Term SIP: HDFC Sec Research Report | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | May 7, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Staggered buying is recommended to benefit from any future falls and have better margin of safety |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | HDFC Sec |
Time To Be Cautious About Some Smallcap And Midcap Stocks: HDFC Sec Report | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | April 29, 2021 |
Type of Report: | Sector Report |
Recommendation: | Sell |
Upside Potential: | 90% |
Summary: | Smallcap and midcap space..is it time to be more selective? |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | HDFC Sec |
Covid 2.0: Investment Ideas | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | April 23, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 39% |
Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities |
Best Cement Stocks To Buy Now: HDFC Sec Research Report | |
Company: | HDFC Sec, Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | April 13, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | long-term trends are likely to drive the cement industry over the next few years |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Best Cement stocks, Sagar Cement Ltd |
Top 5 Pharma Stocks To Buy Now: Edelweiss Research Report | |
Company: | Model Portfolio, Sun Pharma |
Brokerage: | Edelweiss |
Date of report: | April 12, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 22% |
Summary: | SUN PHARMA entering into an earnings upgrade cycle |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | 5 Best Pharma Stocks, Edelweiss |